alprazolam has been researched along with Diabetes Mellitus, Type 2 in 2 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "6%) of whom had a symptomatic generalized anxiety disorder, were entered into a randomized, double-blind, placebo-controlled, 8-week trial using alprazolam (up to 2 mg/day) as the active agent." | 5.08 | Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial. ( Carney, RM; Clouse, RE; Eisen, SA; Freedland, KE; Griffith, LS; Lustman, PJ; McGill, JB; Rubin, EH, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, JF | 1 |
| Yang, W | 1 |
| Xie, YM | 1 |
| Sun, Y | 1 |
| Zhuang, Y | 1 |
| Wang, YY | 1 |
| Lustman, PJ | 1 |
| Griffith, LS | 1 |
| Clouse, RE | 1 |
| Freedland, KE | 1 |
| Eisen, SA | 1 |
| Rubin, EH | 1 |
| Carney, RM | 1 |
| McGill, JB | 1 |
1 trial available for alprazolam and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial.
Topics: Adult; Alprazolam; Analysis of Variance; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Blood Gluc | 1995 |
1 other study available for alprazolam and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Real-world analysis of concurrent diseases and medicine use among patients with insomnia].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alprazolam; Anti-Anxiety Agents; Antipsychotic Agents; B | 2014 |